Radiation Exposure and Surgical Outcomes after Antegrade Sclerotherapy for the Treatment of Varicocele in the Paediatric Population: A Single Centre Experience
- PMID: 36769404
- PMCID: PMC9917517
- DOI: 10.3390/jcm12030755
Radiation Exposure and Surgical Outcomes after Antegrade Sclerotherapy for the Treatment of Varicocele in the Paediatric Population: A Single Centre Experience
Abstract
Introduction: Antegrade sclerotherapy (Tauber) effectively treats varicocele. However, fluoroscopy exposes young males to ionizing radiation. We aimed to evaluate radiation exposure and surgical outcomes after the Tauber procedure.
Materials and methods: We retrospectively analysed data from 251 patients. Dose area product (DAP) and fluoroscopy time were recorded. The effective dose was calculated with the PCXMC software. Descriptive statistics and linear regression tested the association between clinical predictors and radiation exposure.
Results: Median (IQR) age and body mass index (BMI) were 14 (13-16) years and 20.1 (17.9-21.6) kg/m². Five (2.1%) patients developed clinical recurrence and two (0.81%) developed complications. Median fluoroscopy time and DAP were 38.5 (27.7-54.0) s and 89.6 (62.5-143.9) cGy*cm2. The effective dose was 0.19 (0.14-0.31) mSv. Fluoroscopy time was higher in patients with collateral veins (41 (26-49) s vs. 36 (31-61) s, p = 0.02). The median amount of sclerosing agent (SA) used was 3 (3-4) ml. DAP was higher when SA > 3 mL was used (101.4 (65-183) cGy*cm2 vs. 80.5 (59-119) cGy*cm2; p < 0.01). At univariable linear regression, age, BMI, operative time and SA > 3 mL were associated with higher DAP (all p < 0.01). At multivariable linear regression, only BMI (beta 12.9, p < 0.001) and operative time (beta 1.9, p < 0.01) emerged as predictors of higher DAP, after accounting for age and SA > 3 mL.
Conclusions: The Tauber procedure is safe and associated with low effective doses. Operative time and the patient's BMI independently predict a higher radiation dose.
Keywords: Tauber procedure; antegrade sclerotherapy; fluoroscopy; male infertility; paediatric varicocele; radiation exposure; varicocele.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Treatment of varicocele: randomized prospective study on open surgery versus Tauber antegrade sclerotherapy.J Androl. 2005 May-Jun;26(3):328-32. doi: 10.2164/jandrol.04143. J Androl. 2005. PMID: 15866999 Clinical Trial.
-
Antegrade scrotal sclerotherapy for treating primary varicocele in children.BJU Int. 2006 Apr;97(4):809-12. doi: 10.1111/j.1464-410X.2006.06033.x. BJU Int. 2006. PMID: 16536779
-
Antegrade sclerotherapy in adolescent varicocele patients.J Pediatr Urol. 2017 Jun;13(3):305.e1-305.e6. doi: 10.1016/j.jpurol.2016.12.018. Epub 2017 Jan 29. J Pediatr Urol. 2017. PMID: 28215837
-
Efficacy and safety of antegrade sclerotherapy for varicocele in pediatric patients: A systematic review.Urologia. 2024 Aug;91(3):632-637. doi: 10.1177/03915603241252916. Epub 2024 May 20. Urologia. 2024. PMID: 38767314
-
[Antegrade scrotal sclerotherapy of varicocele by the Tauber method].Aktuelle Urol. 2007 Mar;38(2):167-73; quiz 174. doi: 10.1055/s-2005-873218. Aktuelle Urol. 2007. PMID: 17390281 Review. German. No abstract available.
Cited by
-
Varicocele: To Treat or Not to Treat?J Clin Med. 2023 Jun 15;12(12):4062. doi: 10.3390/jcm12124062. J Clin Med. 2023. PMID: 37373755 Free PMC article. Review.
-
Can lifestyle changes significantly improve male fertility: A narrative review?Arab J Urol. 2024 Nov 1;23(3):190-200. doi: 10.1080/20905998.2024.2421626. eCollection 2025. Arab J Urol. 2024. PMID: 40747470 Free PMC article. Review.
-
Scrotal Pain after Varicocelectomy: A Narrative Review.Biomedicines. 2023 Apr 1;11(4):1070. doi: 10.3390/biomedicines11041070. Biomedicines. 2023. PMID: 37189688 Free PMC article. Review.
References
-
- Silay M.S., Hoen L., Quadackaers J., Undre S., Bogaert G., Dogan H.S., Kocvara R., Nijman R.J., Radmayr C., Tekgul S., et al. Treatment of Varicocele in Children and Adolescents: A Systematic Review and Meta-analysis from the European Association of Urology/European Society for Paediatric Urology Guidelines Panel. Eur. Urol. 2019;75:448–461. doi: 10.1016/j.eururo.2018.09.042. - DOI - PubMed
LinkOut - more resources
Full Text Sources